SUPERIOR TRADING COMPANY – Trademark Portfolio

Entity Type: 02

SUPERIOR TRADING COMPANY holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SUPERIOR. The owner is based in SAN FRANCISCO, CA.

867 WASHINGTON ST.

SAN FRANCISCO, CA 94108

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SUPERIOR TRADING COMPANY's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does SUPERIOR TRADING COMPANY have?

SUPERIOR TRADING COMPANY has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.

What trademark classes does SUPERIOR TRADING COMPANY file in?

SUPERIOR TRADING COMPANY files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SUPERIOR TRADING COMPANY's most well-known trademarks?

SUPERIOR TRADING COMPANY's registered trademark portfolio includes well-known marks such as SUPERIOR. These are among 1 currently registered trademark in the portfolio.

What is SUPERIOR TRADING COMPANY's trademark registration success rate?

SUPERIOR TRADING COMPANY has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.